Our Technology
Manufactured in compliance with quality systems
ESI BIO’s human embryonic stem cell (hESC) lines have been derived under conditions that adhere to global ethical standards and conform to regulations controlling clinical-grade cell and tissue development (current Good Tissue Practices) and comply with current Good Manufacturing Practices (cGTPs and cGMPs). ESI BIO's hES cell lines are among the best-characterized and documented lines available today.
These cell lines have been approved by the National Institutes of Health (NIH) and are included in the NIH Stem Cell Registry.
View products »
PureStem® Progenitors
Unique human embryonic progenitor cells
ESI BIO provides clonally pure cultures of human embryonic progenitor cells (hEPC). NIH-registered human embryonic stem cells were cultured under an array of differentiation conditions and time periods, creating hundreds of colonies containing thousands of types of unique transient embryonic progenitor cells. These hEPC are normally transient, existing for a short time in an embryo before they receive a signal to change into the next cell type in its developmental pathway.
These transient progenitors show characteristics not observed in adult stem cells, including differentiation to tissues that may be more appropriate for therapy such as chondrogenic cells that do not express markers of hypertrophic cartilage. They are highly proliferative, producing scalable cultures free of hazardous totipotent cells.
View products »